Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa-Reference-Cited by-同舟云学术

Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa

Published:2017-06-01 Issue:6 Volume:21 Page:670-676
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

van der Heijden Y. F.¹,Karim F.²,Mufamadi G.³,Zako L.³,Chinappa T.³,Shepherd B. E.⁴,Maruri F.¹,Moosa M-Y. S.⁵,Sterling T. R.¹,Pym A. S.²

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

2. KwaZulu-Natal Research Institute for TB and HIV, Durban

3. eThekwini Municipality, Durban, South Africa

4. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

5. Department of Infectious Diseases, Division of Internal Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Epidemiology of Isoniazid-resistant M tuberculosis in Port-au-Prince, Haiti;Open Forum Infectious Diseases;2024-07-18

2. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020;IJTLD OPEN;2024-07-01

3. Incidence, Outcomes, and Risk Factors for Isoniazid-Resistant Tuberculosis from 2012 to 2022 in Eastern China;Antibiotics;2024-04-22

4. Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis;PLOS ONE;2023-07-19

5. Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review;Frontiers in Medicine;2023-06-20